Viewing Study NCT06475820


Ignite Creation Date: 2025-12-25 @ 4:19 AM
Ignite Modification Date: 2026-01-15 @ 3:51 PM
Study NCT ID: NCT06475820
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-08-23
First Post: 2024-05-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Baricitinib at Children and Young Adults With Hemoblastosis
Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module